StockNews.com assumed coverage on shares of USD Partners (NYSE:USDP – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the transportation company’s stock.
USD Partners Stock Performance
USD Partners stock opened at $0.02 on Friday. The stock has a market capitalization of $506,610.00, a price-to-earnings ratio of 0.07 and a beta of 0.69. USD Partners has a 52-week low of $0.01 and a 52-week high of $0.80. The stock’s 50 day moving average price is $0.03 and its two-hundred day moving average price is $0.08.
USD Partners (NYSE:USDP – Get Free Report) last issued its earnings results on Monday, August 12th. The transportation company reported ($0.36) earnings per share (EPS) for the quarter. The company had revenue of $8.88 million for the quarter.
About USD Partners
USD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada. It operates through two segments, Terminalling Services and Fleet Services. The Terminalling Services segment owns and operates Hardisty terminal, an origination terminal for loading various grades of Canadian crude oil onto railcars for transportation to end markets; Stroud terminal, a crude oil destination terminal, which is used to facilitate rail-to-pipeline shipments of crude oil located in Stroud, Oklahoma; Casper terminal, a crude oil storage, blending, and railcar loading terminal located in Casper, Wyoming; and West Colton Terminal, an unit train-capable destination terminals that trans load approximately 13,000 barrels per day ethanol and renewable diesel received by rail from producers onto trucks.
Featured Stories
- Five stocks we like better than USD Partners
- Why Are These Companies Considered Blue Chips?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is Short Interest? How to Use It
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for USD Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USD Partners and related companies with MarketBeat.com's FREE daily email newsletter.